News

On May 27, 2024, the 26th International Congress of Clinical Chemistry and Laboratory Medicine (IFCC Worldlab 2024) was grandly held at the Dubai World Trade Center.

As a global official organization, the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) has members from 119 countries and regions and more than 50,000 expert members. It is one of the most influential organizations in the relevant field in the world. This conference is the first time that IFCC Worldlab has been held in the Middle East, attracting thousands of laboratory medicine experts and scholars from all over the world, as well as 37 leading companies in the industry and many international industry associations.

As one of the important members of IFCC, Autobio brought a number of strategic products and solutions in the fields of immunology, biochemistry, coagulation, etc. to the exhibition, and launched the fully automatic biochemical immunoassay line Autolas B-1 series in the overseas market for the first time. IFCC’s Past President Prof. Khosrow Adeli delivered a speech at the launch ceremony and unveiled the product launch.

Autobio has a deep technical background in the field of immunoassays, a high self-sufficiency rate of core raw materials, and excellent performance in infectious diseases, tumors, thyroid, sex hormones, respiratory pathogens, hypertension and other projects. At present, the company has more than 140 magnetic microparticle chemiluminescence detection projects and 125 biochemical detection projects, with a complete project menu. Rich detection reagents and high-performance detection instruments can meet the diversified clinical detection and intelligence needs of large and medium-sized medical laboratories. In addition, in order to meet the needs of overseas customers for laboratory intelligence, Autobio has independently developed a number of intelligent software systems, which can realize intelligent result review, TAT monitoring, critical value warning, automatic quality control, remote service and other functions.

As soon as the Autolas B-1 series of Autobio's fully automatic biochemical immunoassay assembly line was unveiled at the booth, it attracted many participants to stop and visit. Through interaction and communication with the international business team, they have a deep understanding of Autobio's latest technological achievements in the field of in vitro diagnostics.

Adhering to the tenet of being "committed to the promotion and advancement of medical laboratory technology, dedicated to serving human healthcare", Autobio will continue to increase investment in scientific and technological innovation, enrich its product lines, actively expand the international market, strengthen cooperation and exchanges with outstanding foreign medical institutions, experts and scholars, and provide global customers with more abundant and high-quality products and services.